BIO Bio-Rad Laboratories, Inc.

NYSE
$358.90

Bio-Rad Laboratories, Inc. (BIO) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus BIO's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
3 transactions
Purchases
$0
0 shares
Sales
$1.2M
3,221 shares
Net activity
-$1.2M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.2M 3 transactions · 3,221 shares

Largest single sale: $539.9K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
ENLOE COURTNEY C EVP, General Counsel & Sec Sell 902 $386.17 $348.3K 750 −54.6% of holding
BARRY JAMES EVP, President, LSG Sell 1,400 $385.63 $539.9K 625 −69.1% of holding
DiVincenzo Jonathan P. President & COO Sell 919 $390.47 $358.8K 1,962 −31.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.